India has taken a major step toward advancing stroke treatment with the Technology Development Board (TDB), Department of Science and Technology (DST) funding S3V Vascular Technologies Limited to develop India’s first fully indigenous Mechanical Thrombectomy Kit for the treatment of acute ischemic stroke. The initiative aims to reduce dependency on expensive imported devices and establish a state-of-the-art neuro-intervention manufacturing ecosystem at Medical Devices Park in Oragadam, Chennai.
Mechanical thrombectomy is a life-saving procedure for patients suffering from large vessel occlusion strokes, offering better recovery rates compared to conventional thrombolysis. S3V Vascular Technologies will be the first Indian company to design and manufacture the complete suite of neuro-intervention devices—including microcatheters, aspiration catheters, guidewires, and stent retrievers—at an integrated manufacturing facility.
The company plans to file patents for breakthroughs such as clot retriever head designs and braid-over-coil aspiration catheter structures, further positioning India as a global hub for medical technology innovation. By integrating these devices into government reimbursement programs like Ayushman Bharat, the project seeks to unlock a Rs 166 billion ($2 billion) domestic market, making high-quality stroke treatment accessible across India.
S3V will also collaborate with leading hospitals to provide simulator-based training for interventionalists, especially in Tier-II cities, where stroke cases are more prevalent. Speaking on the development, Rajesh Kumar Pathak, Secretary of TDB, stated: “TDB is proud to support S3V’s vision of building India’s first comprehensive neuro-intervention manufacturing ecosystem. This project underscores our commitment to making India a global leader in affordable, high-end medical technology.”
Managing Director N.G. Vijaya Gopal added that S3V has initiated CE and USFDA approval processes, aiming to expand access to stroke care solutions across Asia, Latin America, Europe, and the U.S.. He emphasized that the initiative will not only reduce reliance on imported devices but also localize the manufacturing of critical raw materials, further strengthening India’s healthcare infrastructure.
With the backing of India’s Technology Development Board, this pioneering effort is set to revolutionize stroke care, ensuring that world-class innovation is designed, engineered, and made in India for the global market.
